Navigation Links
Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
Date:7/27/2009

BETHESDA, Md., July 27 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, August 6, 2009, at 9:00 am Eastern Time (3:00 pm Central European Time) to discuss its financial results for the second quarter of 2009. Micromet anticipates releasing its financial results at 7:00 am Eastern Time (1:00 pm Central European Time) on Thursday, August 6, 2009.

To participate in this conference call, dial 866-730-5770 (U.S.) or 857-350-1594 (international), passcode: 56008602. The audio webcast can be accessed at www.micromet-inc.com.

A replay of the call will be available from 12:00 pm Eastern Time on August 6, 2009 (6:00 pm Central European Time) through Thursday, August 13, 2009. The replay number is 888-286-8010 (U.S.) or 617-801-6888 (international), passcode: 59290657.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class of antibodies that activate the T cells of a patient's immune system to eliminate cancer cells. Five of Micromet's antibodies are currently in clinical trials. Its BiTE antibody blinatumomab (MT103) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the treatment of patients wit
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
2. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
3. Micromet, Inc. Reports Third Quarter 2008 Financial Results
4. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
5. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
6. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
7. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
8. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
9. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
10. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... sciences product development company that identifies and advances ... various stages of development, today provided an update ... the merger of Cytopia Ltd. into YM, details ... The board of directors of Cytopia has unanimously ...
(Date:12/10/2009)... Iowa, Dec. 10 Vivakor, Inc. ... it has entered into an exclusive, $5 ... Regeneca International, Inc. ( www.regeneca.com ). ... rights to a new cutting-edge nutraceutical formulation ... development of future formulations by Vivakor for ...
(Date:12/10/2009)... (NASDAQ: MATK) announced today that it has entered into ... Fonterra Co-operative Group Limited for the use of Martek’s products ... pregnant and nursing mothers. , ... ... Corporation (NASDAQ: MATK) announced today that it has entered ...
(Date:12/10/2009)... Dec. 10 Northwest Biotherapeutics, Inc. ("NWBT" or ... Robert A. Farmer has joined the company,s Board of ... and Harvard Law School, currently serves on six other ... the national treasurer of four presidential campaigns, including those ... Glenn. In those roles, he led fundraising of ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... 25 Tengion Inc., a clinical stage regenerative medicine company focused ... Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present ... 2, 2008 at 9:50 a.m. EST at The Palace Hotel in ... About Tengion , , ...
... /PRNewswire-Asia/ -- ScinoPharm, an active,pharmaceutical ingredient (API) specialist, ... entitled "Novel Crystal Forms of Irinotecan,Hydrochloride." The new ... and processes for their preparation as well as,pharmaceutical ... treating,metastatic carcinoma of the colon or rectum using ...
... Nov. 24 3SBio Inc. (Nasdaq: SSRX ... marketing biopharmaceutical products primarily in China,announced that Dr. Yingfei ... 20th Annual Health Care Conference in New York on ... The presentation will be ...
Other Biology Technology:ScinoPharm Granted US Patent for Novel Crystal Forms 2
(Date:12/14/2009)... you are spending the holidays with big Uncle Frank ... be better off with another family, spare a thought ... team from McMaster University and the University of New ... that lives in groups, members make strategic decisions about ... the current issue of Biology Letters . , ...
(Date:12/14/2009)... MODA Technology Partners, a global software ... product testing for the Pharmaceutical industry, today announced ... third generation mobile data acquisition platform. The latest ... automate their regulated manufacturing processes. ,, MODA ... Fully-Configurable Test Methods: Each test method ...
(Date:12/13/2009)... Conn.A team led by Yale University researchers has ... blood for the first time. Their findings, which ... of Nature Nanotechnology , could dramatically simplify ... and other diseases. , The teamled ... Engineering & Applied Science, and Tarek Fahmy, an ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 1Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 1Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 3InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 1InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 2
... part of our daily vocabulary. We all know they,re part ... pastas. We know they have something to do with starches ... still a lot for science to learn about them. ... said Nikki Pohl, an Iowa State University associate professor of ...
... have made a major new advance in taking waste heat ... technology that can improve the energy efficiency of diesel engines, ... industry. , This heat-actuated cooling system, which will probably find ... applied to automobiles, factories or other places where waste heat ...
... Washington, D.C.April 1, 2009For the past several decades, evidence ... folate, offers protection against the development of certain common ... new avenues for public health interventions that have a ... an essential factor in DNA synthesis also means that ...
Other Biology News:Iowa State chemist synthesizes carbohydrates, launches startup company 2Breakthrough made in energy efficiency, use of waste heat 2Breakthrough made in energy efficiency, use of waste heat 3Health benefits, consequences of folic acid dependent on circumstances 2
...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Nabeta2. The epitope specific for ... any other known proteins.,SPECIES REACTIVITIES: ... work on human because the ... (17/19 residues). Reactivity with other ...
Biology Products: